首頁 > 市場調查報告書 > 製藥

生物製劑基因治療學和RNAi

生物製造中病毒檢測和定量的全球市場（2023-2032）：按產品類型、技術、用途、最終用戶和地區進行分析和預測

市場調查報告書

商品編碼

1316427

生物製造中病毒檢測和定量的全球市場（2023-2032）：按產品類型、技術、用途、最終用戶和地區進行分析和預測

Biomanufacturing Viral Detection and Quantification Market - A Global and Regional Analysis: Focus on Offering Type, Technology, Application, End User, and Region - Analysis and Forecast, 2023-2032

出版日期: 2023年07月17日 | 出版商:

BIS Research | 英文 273 Pages | 商品交期: 1-5個工作天內

價格

簡介目錄圖表

行業概況

全球生物製造中的病毒檢測和定量市場規模將從2022年的 4.743 億美元增至2032年的 11.497 億美元，預測期內年複合成長率為 9.37%

生物製藥利用率的提高和病毒檢測行業的技術進步預計將推動市場的成長。

主要市場統計資料
開始年份	2023年
預測年份	2032
第一年市場規模	5.134 億美元（2023年）
市場規模預測	11.497 億美元（2032年）
年複合成長率（%）：	9.37%

市場生命週期階段

全球生物製造中的病毒檢測和定量市場正處於持續發展階段。由於生物製藥的日益普及，市場蓬勃發展。穩健的品質控制流程對於確保生物製藥的安全性、有效性和一致性非常重要。因此，生物製藥製造過程中對量化病毒污染物的消耗品和儀器的需求不斷增加預測將推動市場成長。

從產品類型來看，消耗品細分市場將在2022年佔據較大佔有率。試劑盒、檢測方法和配件的採用增加促進了該領域的成長。消耗品是在整個病毒檢測過程中不斷消耗的產品或材料，有幾種消耗品是在生物製造過程中用於病毒檢測和定量以簡化病毒樣本的檢測和分析所使用的。

從技術來看，PCR 技術領域將佔據較大佔有率，並在2022年引領市場。聚合酶鍊式反應（PCR）是分子生物學和病毒檢測領域常用的技術。此外，從用途來看，血液及血液製品製造業佔有較大佔有率，並將在2022年引領市場。病毒檢測是確保生物製造過程中血液和血液製品安全和品質的重要組成部分。該測試識別並測量血液樣本中存在的病毒顆粒和病毒核酸。採用核酸擴增測試（NAT）等方法來識別和測量病毒核酸。

從最終用戶來看，生命科學公司將在2022年佔據最大佔有率。生命科學中的病毒檢測和定量是指在藥物開發、製造和評估過程中對病毒顆粒或病毒成分的測量和評估。病毒載量的檢測和定量，即每個樣品或系統中存在的病毒的量或濃度，是該領域的基本要求。

按地區分類，由於主要參與者的存在和資金的增加，北美市場將在2022年佔據最大佔有率，達到 38.72%。另一方面，由於持續的研發和支持性的監管環境，預計亞太地區在預測期內將以 10.47%的年複合成長率實現最大成長。

本報告研究了生物製造中的病毒檢測和定量市場，提供了市場概況、法律和監管框架、各種業務影響因素和商機的分析、市場規模趨勢和預測、各個細分市場和地區的深入分析，競爭格局、主要參與者簡介等整理。

概述
公司股份分析
生物製造中病毒檢測和定量生態系統中的公司
Danaher Corporation
Merck KGaA
New England Biolabs
TAKARA HOLDINGS INC.
Thermo Fisher Scientific Inc.
Agilent Technologies, Inc.
Sartorius AG
Charles River Laboratories
Bio-Rad Laboratories, Inc.
PerkinElmer, Inc.
Promega Corporation
QIAGEN NV
Genscript Biotech Corporation
Norgen Biotek Corp.

簡介目錄圖表

Product Code: BHL1392SA

“Global Biomanufacturing Viral Detection and Quantification Market to Reach $1,149.7 Million by 2032.”

Industry Overview

The global biomanufacturing viral detection and quantification market was valued at $474.3 million in 2022 and is anticipated to reach $1,149.7 million by 2032, witnessing a CAGR of 9.37% during the forecast period 2023-2032. The global biomanufacturing viral detection and quantification market is expected to be driven by the rising utilization of biopharmaceutical products and the technological advancements in the viral testing industry.

KEY MARKET STATISTICS
Start Year	2023
Forecast Year	2032
Start Value	$513.4 Million in 2023
Forecast Value	$1,149.7 Million by 2032
CAGR %	9.37%

Market Lifecycle Stage

The global biomanufacturing viral detection and quantification market is in progressing phase. The biomanufacturing viral detection and quantification market is experiencing rapid growth due to the increasing adoption of biopharmaceuticals. Robust quality control processes are essential to ensure the safety, efficacy, and consistency of biopharmaceuticals. These factors are expected to drive the demand for consumables and instruments for quantification of viral contaminants during biomanufacturing of biologics, thereby augmenting the growth of the biomanufacturing viral detection and quantification market.

Impact

Viral detection and quantification is used to evaluate and improve the biomanufacturing process throughout process development. Manufacturers can detect potential viral contamination sources and make the required adjustments to reduce risks and boost process effectiveness by detecting and quantifying viral contaminants at different stages. Emerging cell and gene therapies, along with other biotherapeutics, are at risk of contamination, including viral contaminants. Detecting these contaminants early on is important to prevent any delays in the production process, which can have a direct impact on the commercialization of therapy. Cell and gene therapies utilize viral vectors to deliver therapeutic genes or manipulate cells for therapeutic purposes. In addition, the entry of several established players, such as Thermo Fisher Scientific Inc., Merck KGaA, Charles River Laboratories, Bio-Rad Laboratories, Inc., QIAGEN N.V., and others, is expected to aid the market growth.

Due to better cleanliness, people witnessed global advancement in the control of infectious contamination over the past few years. The market for biomanufacturing viral detection and quantification is expanding due to the growing demand for precise viral testing in the biomanufacturing of therapies. In conclusion, as the field of emerging cell and gene therapies continues to advance, it is imperative to address the potential risks of viral contamination.

Market Segmentation:

Segmentation 1: by Offering Type

Consumables
Instruments
Services

Consumables Segment Accounted for Major Share in the Global Biomanufacturing Viral Detection and Quantification Market (by Offering Type)

Based on offering type, the consumables segment dominated the global biomanufacturing viral detection and quantification market in FY2022. The increasing adoption of kits, assays, and accessories contributed to the prominence of the consumables segment. Consumables are products and materials that are constantly consumed throughout the viral testing process. Several consumables are utilized in viral detection and quantification during biomanufacturing to simplify testing and analysis of viral samples. These consumables are necessary to carry out the several procedures and tests required to determine the quantity or concentration of a particular virus in a biological sample.

Segmentation 2: by Technology

PCR
ELISA
Flow Cytometry
Plaque Assay
Others

PCR Technology Segment Accounted for Major Share in the Global Biomanufacturing Viral Detection and Quantification Market (by Technology)

Based on technology, the PCR segment dominated the global biomanufacturing viral detection and quantification market in FY2022. In the field of molecular biology and viral testing, polymerase chain reaction (PCR) is a commonly used technique. It is a method for identifying and measuring viral nucleic acids that are sensitive and focused during the production of biopharmaceuticals. In addition, PCR is essential for measuring the viral load, or the quantity of viral genetic material, in a biological sample.

Segmentation 3: by Application

Blood and Blood Products Manufacturing
Vaccines and Therapeutics Manufacturing
Cellular and Gene Therapy Products Manufacturing
Stem Cell Products Manufacturing
Tissue and Tissue Products Manufacturing

Blood and Blood Products Manufacturing Segment Accounted for Major Share in the Global Biomanufacturing Viral Detection and Quantification Market (by Application)

Based on application, the global biomanufacturing viral detection and quantification market was dominated by the blood and blood products manufacturing segment in FY2022. In biomanufacturing processes, viral testing is an essential component in verifying the safety and quality of blood and blood products. This test involves identifying and measuring viral particles or viral nucleic acids that are present in blood samples. To identify and measure viral nucleic acids, methods such as nucleic acid amplification testing (NAT) are often employed.

Segmentation 4: by End User

Life Science Companies
Testing Laboratories
CROs and CDMOs

Life Science Companies to Continue its Dominance in the End User Segment

Based on end user, the life science companies segment accounted for the largest share of the global biomanufacturing viral detection and qauntification market in FY2022. In the life science sector, viral detection and quantification refers to the measuring and evaluation of viral particles or viral components at distinct stages of medication development, production, and evaluation. Viral load, or the quantity or concentration of viruses present in each sample or system, must be detected and quantified.

Segmentation 5: by Region

North America
Europe
Asia-Pacific
Latin America
Middle East and Africa

North America held the largest share of 38.72% in 2022 in the global biomanufacturing viral detection and quantification market, owing to the presence of most key players and rising funding in the region.

In addition, Asia-Pacific is expected to grow at the highest CAGR of 10.47% in the forecast period 2023-2032, owing to the continuous research and development in the viral detection and quantification industry as well as the supportive regulatory landscape.

Demand - Drivers and Limitations

Market Demand Drivers:

Increasing Utilization of Biopharmaceuticals
Technological Advancements in Viral Detection and Quantification

Market Restraints:

High Cost of Advanced Viral Detection and Quantification Equipment
Lack of Trained Professionals in the Field of Viral Detection and Quantification

Market Opportunities:

Increasing Need in Viral Contamination Considerations for the Development of Cell and Gene Therapies

How can this report add value to an organization?

Workflow/Innovation Strategy: The biomanufacturing viral detection and quantification market (by offering type) has been segmented into consumables, instruments, and services. Moreover, the study provides the reader with a detailed understanding of the different applications of biomanufacturing viral detection and quantification in raw material preparation, upstream processing, downstream processing, and packaging.

Growth/Marketing Strategy: Biomanufacturing viral detection and quantification is being used for raw material preparation, upstream processing, downstream processing, and packaging. Various companies are providing products and services to aid in the viral testing of various biologic production, which is also the key strategy for market players to excel in the current biomanufacturing viral detection and quantification market.

Competitive Strategy: Key players in the global biomanufacturing viral detection and quantification market have been analyzed and profiled in the study, including manufacturers. Moreover, a detailed competitive benchmarking of the players operating in the global biomanufacturing viral detection and quantification market has been done to help the reader understand how players stack against each other, presenting a clear market landscape.

Key Market Players and Competition Synopsis

Viral contamination poses a significant risk to both animal- and human-derived biopharmaceuticals. This form of contamination can occur at any stage of the bioproduction process, necessitating viral testing studies and the implementation of viral clearance methods by biomanufacturers. In this study, several types of fundamental technologies have been examined that have facilitated these advances, namely, polymerase chain reaction (PCR), plaque assays, flow cytometry, and enzyme-linked immunosorbent assay (ELISA), among others. The global biomanufacturing viral detection and quantification market is strongly driven by the continuous introduction of new technologies as well as increased investments and funding from both the government and private sectors.

Key Companies Profiled:

Danaher Corporation
Merck KGaA
New England Biolabs
TAKARA HOLDINGS INC.
Thermo Fisher Scientific Inc.
Agilent Technologies, Inc.
Sartorius AG

Charles River Laboratories
Bio-Rad Laboratories, Inc.
PerkinElmer, Inc.
Promega Corporation
QIAGEN N.V.
Genscript Biotech Corporation
Norgen Biotek Corp.

1 Product Definition

1.1 Inclusion and Exclusion Criteria

2 Market Scope

2.1 Scope of the Study
2.2 Key Questions Answered in the Report

3 Research Methodology

4 Market Overview

4.1 Overview
4.2 Current Market Size and Future Growth Potential, $Billion, 2022-2032

5 Industry Outlook

5.1 Regulatory Landscape
- 5.1.1 Legal Requirements and Frameworks in the U.S.
  - 5.1.1.1 Marketing Authorization
- 5.1.2 Legal Requirements and Frameworks in Europe
- 5.1.3 Legal Requirements and Frameworks in Asia-Pacific
  - 5.1.3.1 Legal Requirements and Framework in Japan

6 Global Biomanufacturing Viral Detection and Quantification Market: Market Dynamics

6.1 Business Drivers
- 6.1.1 Increasing Utilization of Biopharmaceuticals
- 6.1.2 Technological Advancements in Viral Detection and Quantification
- 6.1.3 Impact Analysis
6.2 Business Restraints
- 6.2.1 High Cost of Advanced Viral Detection and Quantification Equipment
- 6.2.2 Lack of Trained Professionals in the Field of Viral Detection and Quantification
- 6.2.3 Impact Analysis
6.3 Business Opportunities
- 6.3.1 Increasing Need in Viral Contamination Considerations for the Development of Cell and Gene Therapies

7 Global Biomanufacturing Viral Detection and Quantification Market (by Offering Type), Value ($Million), 2022-2032

7.1 Overview
7.2 Consumables
- 7.2.1 Kits and Assays
- 7.2.2 Accessories
7.3 Instruments
7.4 Services

8 Global Biomanufacturing Viral Detection and Quantification Market (by Technology), Value ($Million), 2022-2032

8.1 Overview
8.2 PCR
8.3 Flow Cytometry
8.4 ELISA
8.5 Plaque Assay
8.6 Others

9 Global Biomanufacturing Viral Detection and Quantification Market (by Application), Value ($Million), 2022-2032

9.1 Overview
9.2 Blood and Blood Products Manufacturing
9.3 Cellular and Gene Therapy Products Manufacturing
9.4 Stem Cell Products Manufacturing
9.5 Tissue and Tissue Products Manufacturing
9.6 Vaccines and Therapeutics Manufacturing

10 Global Biomanufacturing Viral Detection and Quantification Market (by End User), Value ($Million), 2022-2032

10.1 Overview
10.2 Life Science Companies
10.3 Testing Laboratories
10.4 CROs and CDMOs

11 Global Biomanufacturing Viral Detection and Quantification Market (by Region), Value ($Million), 2022-2032

11.1 Overview
11.2 North America
- 11.2.1 North America Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
- 11.2.2 North America Biomanufacturing Viral Detection and Quantification Market (by Technology)
- 11.2.3 North America Biomanufacturing Viral Detection and Quantification Market (by Application)
- 11.2.4 North America Biomanufacturing Viral Detection and Quantification Market (by End User)
- 11.2.5 North America Biomanufacturing Viral Detection and Quantification Market (by Country)
  - 11.2.5.1 U.S.
    - 11.2.5.1.1 U.S. Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
    - 11.2.5.1.2 U.S. Biomanufacturing Viral Detection and Quantification Market (by Technology)
    - 11.2.5.1.3 U.S. Biomanufacturing Viral Detection and Quantification Market (by Application)
    - 11.2.5.1.4 U.S. Biomanufacturing Viral Detection and Quantification Market (by End User)
  - 11.2.5.2 Canada
    - 11.2.5.2.1 Canada Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
    - 11.2.5.2.2 Canada Biomanufacturing Viral Detection and Quantification Market (by Technology)
    - 11.2.5.2.3 Canada Biomanufacturing Viral Detection and Quantification Market (by Application)
    - 11.2.5.2.4 Canada Biomanufacturing Viral Detection and Quantification Market (by End User)
11.3 Europe
- 11.3.1 Europe Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
- 11.3.2 Europe Biomanufacturing Viral Detection and Quantification Market (by Technology)
- 11.3.3 Europe Biomanufacturing Viral Detection and Quantification Market (by Application)
- 11.3.4 Europe Biomanufacturing Viral Detection and Quantification Market (by End User)
- 11.3.5 Europe Biomanufacturing Viral Detection and Quantification Market (by Country)
  - 11.3.5.1 Germany
    - 11.3.5.1.1 Germany Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
    - 11.3.5.1.2 Germany Biomanufacturing Viral Detection and Quantification Market (by Technology)
    - 11.3.5.1.3 Germany Biomanufacturing Viral Detection and Quantification Market (by Application)
    - 11.3.5.1.4 Germany Biomanufacturing Viral Detection and Quantification Market (by End User)
  - 11.3.5.2 U.K.
    - 11.3.5.2.1 U.K. Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
    - 11.3.5.2.2 U.K. Biomanufacturing Viral Detection and Quantification Market (by Technology)
    - 11.3.5.2.3 U.K. Biomanufacturing Viral Detection and Quantification Market (by Application)
    - 11.3.5.2.4 U.K. Biomanufacturing Viral Detection and Quantification Market (by End User)
  - 11.3.5.3 France
    - 11.3.5.3.1 France Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
    - 11.3.5.3.2 France Biomanufacturing Viral Detection and Quantification Market (by Technology)
    - 11.3.5.3.3 France Biomanufacturing Viral Detection and Quantification Market (by Application)
    - 11.3.5.3.4 France Biomanufacturing Viral Detection and Quantification Market (by End User)
  - 11.3.5.4 Spain
    - 11.3.5.4.1 Spain Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
    - 11.3.5.4.2 Spain Biomanufacturing Viral Detection and Quantification Market (by Technology)
    - 11.3.5.4.3 Spain Biomanufacturing Viral Detection and Quantification Market (by Application)
    - 11.3.5.4.4 Spain Biomanufacturing Viral Detection and Quantification Market (by End User)
  - 11.3.5.5 Italy
    - 11.3.5.5.1 Italy Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
    - 11.3.5.5.2 Italy Biomanufacturing Viral Detection and Quantification Market (by Technology)
    - 11.3.5.5.3 Italy Biomanufacturing Viral Detection and Quantification Market (by Application)
    - 11.3.5.5.4 Italy Biomanufacturing Viral Detection and Quantification Market (by End User)
  - 11.3.5.6 Rest-of-Europe
    - 11.3.5.6.1 Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
    - 11.3.5.6.2 Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by Technology)
    - 11.3.5.6.3 Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by Application)
    - 11.3.5.6.4 Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by End User)
11.4 Asia-Pacific
- 11.4.1 Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
- 11.4.2 Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Technology)
- 11.4.3 Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Application)
- 11.4.4 Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by End User)
- 11.4.5 Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Country)
  - 11.4.5.1 China
    - 11.4.5.1.1 China Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
    - 11.4.5.1.2 China Biomanufacturing Viral Detection and Quantification Market (by Technology)
    - 11.4.5.1.3 China Biomanufacturing Viral Detection and Quantification Market (by Application)
    - 11.4.5.1.4 China Biomanufacturing Viral Detection and Quantification Market (by End User)
  - 11.4.5.2 Japan
    - 11.4.5.2.1 Japan Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
    - 11.4.5.2.2 Japan Biomanufacturing Viral Detection and Quantification Market (by Technology)
    - 11.4.5.2.3 Japan Biomanufacturing Viral Detection and Quantification Market (by Application)
    - 11.4.5.2.4 Japan Biomanufacturing Viral Detection and Quantification Market (by End User)
  - 11.4.5.3 India
    - 11.4.5.3.1 India Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
    - 11.4.5.3.2 India Biomanufacturing Viral Detection and Quantification Market (by Technology)
    - 11.4.5.3.3 India Biomanufacturing Viral Detection and Quantification Market (by Application)
    - 11.4.5.3.4 India Biomanufacturing Viral Detection and Quantification Market (by End User)
  - 11.4.5.4 Australia
    - 11.4.5.4.1 Australia Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
    - 11.4.5.4.2 Australia Biomanufacturing Viral Detection and Quantification Market (by Technology)
    - 11.4.5.4.3 Australia Biomanufacturing Viral Detection and Quantification Market (by Application)
    - 11.4.5.4.4 Australia Biomanufacturing Viral Detection and Quantification Market (by End User)
  - 11.4.5.5 South Korea
    - 11.4.5.5.1 South Korea Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
    - 11.4.5.5.2 South Korea Biomanufacturing Viral Detection and Quantification Market (by Technology)
    - 11.4.5.5.3 South Korea Biomanufacturing Viral Detection and Quantification Market (by Application)
    - 11.4.5.5.4 South Korea Biomanufacturing Viral Detection and Quantification Market (by End User)
  - 11.4.5.6 Rest-of-Asia-Pacific
    - 11.4.5.6.1 Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
    - 11.4.5.6.2 Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Technology)
    - 11.4.5.6.3 Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Application)
    - 11.4.5.6.4 Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by End User)
11.5 Latin America
- 11.5.1 Latin America Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
- 11.5.2 Latin America Biomanufacturing Viral Detection and Quantification Market (by Technology)
- 11.5.3 Latin America Biomanufacturing Viral Detection and Quantification Market (by Application)
- 11.5.4 Latin America Biomanufacturing Viral Detection and Quantification Market (by End User)
  - 11.5.4.1 Brazil
    - 11.5.4.1.1 Brazil Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
    - 11.5.4.1.2 Brazil Biomanufacturing Viral Detection and Quantification Market (by Technology)
    - 11.5.4.1.3 Brazil Biomanufacturing Viral Detection and Quantification Market (by Application)
    - 11.5.4.1.4 Brazil Biomanufacturing Viral Detection and Quantification Market (by End User)
  - 11.5.4.2 Mexico
    - 11.5.4.2.1 Mexico Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
    - 11.5.4.2.2 Mexico Biomanufacturing Viral Detection and Quantification Market (by Technology)
    - 11.5.4.2.3 Mexico Biomanufacturing Viral Detection and Quantification Market (by Application)
    - 11.5.4.2.4 Mexico Biomanufacturing Viral Detection and Quantification Market (by End User)
  - 11.5.4.3 Rest-of-Latin America
    - 11.5.4.3.1 Rest-of-Latin America Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
    - 11.5.4.3.2 Rest-of-Latin America Biomanufacturing Viral Detection and Quantification Market (by Technology)
    - 11.5.4.3.3 Rest-of-Latin America Biomanufacturing Viral Detection and Quantification Market (by Application)
    - 11.5.4.3.4 Rest-of-Latin America Biomanufacturing Viral Detection and Quantification Market (by End User)
11.6 Middle East and Africa
- 11.6.1 Middle East and Africa Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
- 11.6.2 Middle East and Africa Biomanufacturing Viral Detection and Quantification Market (by Technology)
- 11.6.3 Middle East and Africa Biomanufacturing Viral Detection and Quantification Market (by Application)
- 11.6.4 Middle East and Africa Biomanufacturing Viral Detection and Quantification Market (by End User)
  - 11.6.4.1 South Africa
    - 11.6.4.1.1 South Africa Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
    - 11.6.4.1.2 South Africa Biomanufacturing Viral Detection and Quantification Market (by Technology)
    - 11.6.4.1.3 South Africa Biomanufacturing Viral Detection and Quantification Market (by Application)
    - 11.6.4.1.4 South Africa Biomanufacturing Viral Detection and Quantification Market (by End User)
  - 11.6.4.2 Israel
    - 11.6.4.2.1 Israel Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
    - 11.6.4.2.2 Israel Biomanufacturing Viral Detection and Quantification Market (by Technology)
    - 11.6.4.2.3 Israel Biomanufacturing Viral Detection and Quantification Market (by Application)
    - 11.6.4.2.4 Israel Biomanufacturing Viral Detection and Quantification Market (by End User)
  - 11.6.4.3 U.A.E.
    - 11.6.4.3.1 U.A.E. Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
    - 11.6.4.3.2 U.A.E. Biomanufacturing Viral Detection and Quantification Market (by Technology)
    - 11.6.4.3.3 U.A.E. Biomanufacturing Viral Detection and Quantification Market (by Application)
    - 11.6.4.3.4 U.A.E. Biomanufacturing Viral Detection and Quantification Market (by End User)
  - 11.6.4.4 Saudi Arabia
    - 11.6.4.4.1 Saudi Arabia Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
    - 11.6.4.4.2 Saudi Arabia Biomanufacturing Viral Detection and Quantification Market (by Technology)
    - 11.6.4.4.3 Saudi Arabia Biomanufacturing Viral Detection and Quantification Market (by Application)
    - 11.6.4.4.4 Saudi Arabia Biomanufacturing Viral Detection and Quantification Market (by End User)
  - 11.6.4.5 Rest-of-Middle East and Africa
    - 11.6.4.5.1 Rest-of-Middle East and Africa Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
    - 11.6.4.5.2 Rest-of-Middle East and Africa Biomanufacturing Viral Detection and Quantification Market (by Technology)
    - 11.6.4.5.3 Rest-of-Middle East and Africa Biomanufacturing Viral Detection and Quantification Market (by Application)
    - 11.6.4.5.4 Rest-of-Middle East and Africa Biomanufacturing Viral Detection and Quantification Market (by End User)

12 Markets - Competitive Benchmarking & Company Profiles

12.1 Overview
12.2 Company Share Analysis
12.3 Biomanufacturing Viral Detection and Quantification Ecosystem Active Players
12.4 Danaher Corporation
- 12.4.1 Company Overview
- 12.4.2 Role of Danaher Corporation in the Global Biomanufacturing Viral Detection and Quantification Market
- 12.4.3 Key Competitors
- 12.4.4 Financials
- 12.4.5 Key Insights about the Financial Health of the Company
- 12.4.6 Analyst Perspective
12.5 Merck KGaA
- 12.5.1 Company Overview
- 12.5.2 Role of Merck KGaA in the Global Biomanufacturing Viral Detection and Quantification Market
- 12.5.3 Key Competitors
- 12.5.4 Financials
- 12.5.5 Key Insights about the Financial Health of the Company
- 12.5.6 Analyst Perspective
12.6 New England Biolabs
- 12.6.1 Company Overview
- 12.6.2 Role of New England Biolabs in the Global Biomanufacturing Viral Detection and Quantification Market
- 12.6.3 Key Competitors
- 12.6.4 Analyst Perspective
12.7 TAKARA HOLDINGS INC.
- 12.7.1 Company Overview
- 12.7.2 Role of TAKARA HOLDINGS INC. in the Global Biomanufacturing Viral Detection and Quantification Market
- 12.7.3 Key Competitors
- 12.7.4 Financials
- 12.7.5 Key Insights about the Financial Health of the Company
- 12.7.6 Analyst Perspective
12.8 Thermo Fisher Scientific Inc.
- 12.8.1 Company Overview
- 12.8.2 Role of Thermo Fisher Scientific Inc. in the Global Biomanufacturing Viral Detection and Quantification Market
- 12.8.3 Key Competitors
- 12.8.4 Financials
- 12.8.5 Key Insights about the Financial Health of the Company
- 12.8.6 Analyst Perspective
12.9 Agilent Technologies, Inc.
- 12.9.1 Company Overview
- 12.9.2 Role of Agilent Technologies, Inc. in the Global Biomanufacturing Viral Detection and Quantification Market
- 12.9.3 Key Competitors
- 12.9.4 Financials
- 12.9.5 Key Insights about the Financial Health of the Company
- 12.9.6 Analyst Perspective
12.1 Sartorius AG
- 12.10.1 Company Overview
- 12.10.2 Role of Sartorius AG in the Global Biomanufacturing Viral Detection and Quantification Market
- 12.10.3 Key Competitors
- 12.10.4 Financials
- 12.10.5 Analyst Perspective
12.11 Charles River Laboratories
- 12.11.1 Company Overview
- 12.11.2 Role of Charles River Laboratories in the Global Biomanufacturing Viral Detection and Quantification Market
- 12.11.3 Key Competitors
- 12.11.4 Financials
- 12.11.5 Analyst Perspective
12.12 Bio-Rad Laboratories, Inc.
- 12.12.1 Company Overview
- 12.12.2 Role of Bio-Rad Laboratories, Inc. in the Global Biomanufacturing Viral Detection and Quantification Market
- 12.12.3 Key Competitors
- 12.12.4 Financials
- 12.12.5 Key Insights about the Financial Health of the Company
- 12.12.6 Analyst Perspective
12.13 PerkinElmer, Inc.
- 12.13.1 Company Overview
- 12.13.2 Role of PerkinElmer, Inc. in the Global Biomanufacturing Viral Detection and Quantification Market
- 12.13.1 Key Competitors
- 12.13.2 Financials
- 12.13.3 Key Insights about the Financial Health of the Company
- 12.13.4 Analyst Perspective
12.14 Promega Corporation
- 12.14.1 Company Overview
- 12.14.2 Role of Promega Corporation in the Global Biomanufacturing Viral Detection and Quantification Market
- 12.14.3 Key Competitors
- 12.14.4 Analyst Perspective
12.15 QIAGEN N.V.
- 12.15.1 Company Overview
- 12.15.2 Role of QIAGEN N.V. in the Global Biomanufacturing Viral Detection and Quantification Market
- 12.15.3 Key Competitors
- 12.15.4 Financials
- 12.15.5 Key Insights about the Financial Health of the Company
- 12.15.6 Analyst Perspective
12.16 Genscript Biotech Corporation
- 12.16.1 Company Overview
- 12.16.2 Role of Genscript Biotech Corporation in the Global Biomanufacturing Viral Detection and Quantification Market
- 12.16.3 Key Competitors
- 12.16.4 Financials
- 12.16.5 Key Insights about the Financial Health of the Company
- 12.16.6 Analyst Perspective
12.17 Norgen Biotek Corp.
- 12.17.1 Company Overview
- 12.17.2 Role of Norgen Biotek Corp. in the Global Biomanufacturing Viral Detection and Quantification Market
- 12.17.3 Key Competitors
- 12.17.4 Analyst Perspective

簡介目錄圖表

List of Figures

Figure 1: Global Biomanufacturing Viral Detection and Quantification Market, $Billion, 2022-2032
Figure 2: Global Biomanufacturing Viral Detection and Quantification Market: Drivers, Restraints, and Opportunities
Figure 3: Global Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Billion, 2022-2032
Figure 4: Global Biomanufacturing Viral Detection and Quantification Market (by Technology), $Billion, 2022-2032
Figure 5: Global Biomanufacturing Viral Detection and Quantification Market (by Application), $Billion, 2022-2032
Figure 6: Global Biomanufacturing Viral Detection and Quantification Market (by Region), $Billion, 2022 and 2032
Figure 7: Global Biomanufacturing Viral Detection and Quantification Market Segmentation
Figure 8: Global Biomanufacturing Viral Detection and Quantification Market: Research Methodology
Figure 9: Primary Research Methodology
Figure 10: Bottom-Up Approach (Segment-Wise Analysis)
Figure 11: Top-Down Approach (Segment-Wise Analysis)
Figure 12: Global Biomanufacturing Viral Detection and Quantification Market, $Billion, 2022-2032
Figure 13: Steps Involved in FDA Regulation
Figure 14: Steps for Obtaining Marketing Authorization
Figure 15: Global Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
Figure 16: Global Biomanufacturing Viral Detection and Quantification Market (Consumables), $Billion, 2022-2032
Figure 17: Global Biomanufacturing Viral Detection and Quantification Market (Kits and Assays), $Billion, 2022-2032
Figure 18: Global Biomanufacturing Viral Detection and Quantification Market (Accessories), $Billion, 2022-2032
Figure 19: Global Biomanufacturing Viral Detection and Quantification Market (Instruments), $Billion, 2022-2032
Figure 20: Global Biomanufacturing Viral Detection and Quantification Market (Services), $Billion, 2022-2032
Figure 21: Global Biomanufacturing Viral Detection and Quantification Market (by Technology)
Figure 22: Steps Involved in PCR for Viral Detection and Quantification
Figure 23: Global Biomanufacturing Viral Detection and Quantification Market (PCR), $Billion, 2022-2032
Figure 24: Steps Involved in Flow Cytometry for Viral Detection and Quantification
Figure 25: Global Biomanufacturing Viral Detection and Quantification Market (Flow Cytometry), $Billion, 2022-2032
Figure 26: Steps Involved in ELISA for Viral Detection and Quantification
Figure 27: Global Biomanufacturing Viral Detection and Quantification Market (ELISA), $Billion, 2022-2032
Figure 28: Global Biomanufacturing Viral Detection and Quantification Market (Plaque Assay), $Billion, 2022-2032
Figure 29: Global Biomanufacturing Viral Detection and Quantification Market (Others), $Billion, 2022-2032
Figure 30: Global Biomanufacturing Viral Detection and Quantification Market (by Application)
Figure 31: Global Biomanufacturing Viral Detection and Quantification Market (Blood and Blood Products Manufacturing), $Billion, 2022-2032
Figure 32: Global Biomanufacturing Viral Detection and Quantification Market (Cellular and Gene Therapy Products Manufacturing), $Billion, 2022-2032
Figure 33: Global Biomanufacturing Viral Detection and Quantification Market (Stem Cell Products Manufacturing), $Billion, 2022-2032
Figure 34: Global Biomanufacturing Viral Detection and Quantification Market (Tissue and Tissue Products Manufacturing), $Billion, 2022-2032
Figure 35: Global Biomanufacturing Viral Detection and Quantification Market (Vaccines and Therapeutics Manufacturing), $Billion, 2022-2032
Figure 36: Global Biomanufacturing Viral Detection and Quantification Market (by End User)
Figure 37: Global Biomanufacturing Viral Detection and Quantification Market (Life Science Companies), $Billion, 2022-2032
Figure 38: Use of Viral Detection and Quantification in Testing Laboratories
Figure 39: Global Biomanufacturing Viral Detection and Quantification Market (Testing Laboratories) $Billion, 2022-2032
Figure 40: Global Biomanufacturing Viral Detection and Quantification Market (CROs and CDMOs) $Billion, 2022-2032
Figure 41: Global Biomanufacturing Viral Detection and Quantification Market (by Region)
Figure 42: North America: Market Dynamics
Figure 43: North America Biomanufacturing Viral Detection and Quantification Market, $Billion, 2022-2032
Figure 44: North America Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 45: North America Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 46: North America Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 47: North America Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 48: U.S. Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 49: U.S. Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 50: U.S. Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 51: U.S. Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 52: U.S. Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 53: Canada Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 54: Canada Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 55: Canada Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 56: Canada Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 57: Canada Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 58: Europe: Market Dynamics
Figure 59: Europe Biomanufacturing Viral Detection and Quantification Market, $Billion, 2022-2032
Figure 60: Europe Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 61: Europe Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 62: Europe Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 63: Europe Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 64: Germany Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 65: Germany Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 66: Germany Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 67: Germany Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 68: Germany Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 69: U.K. Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 70: U.K. Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 71: U.K. Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 72: U.K. Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 73: U.K. Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 74: France Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 75: France Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 76: France Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 77: France Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 78: France Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 79: Spain Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 80: Spain Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 81: Spain Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 82: Spain Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 83: Spain Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 84: Italy Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 85: Italy Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 86: Italy Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 87: Italy Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 88: Italy Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 89: Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 90: Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 91: Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 92: Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 93: Rest-of-Europe Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 94: Measures Undertaken by APAC to Enhance its Viral Testing Capacity
Figure 95: Asia-Pacific: Market Dynamics
Figure 96: Asia-Pacific Biomanufacturing Viral Detection and Quantification Market, $Billion, 2022-2032
Figure 97: Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 98: Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 99: Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 100: Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 101: China Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 102: China Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 103: China Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 104: China Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 105: China Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 106: Japan Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 107: Japan Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 108: Japan Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 109: Japan Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 110: Japan Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 111: India Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 112: India Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 113: India Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 114: India Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 115: India Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 116: Australia Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 117: Australia Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 118: Australia Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 119: Australia Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 120: Australia Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 121: South Korea Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 122: South Korea Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 123: South Korea Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 124: South Korea Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 125: South Korea Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 126: Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 127: Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 128: Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 129: Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 130: Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 131: Latin America: Market Dynamics
Figure 132: Latin America Biomanufacturing Viral Detection and Quantification Market, $Billion, 2022-2032
Figure 133: Latin America Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 134: Latin America Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 135: Latin America Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 136: Latin America Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 137: Brazil Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 138: Brazil Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 139: Brazil Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 140: Brazil Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 141: Brazil Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 142: Mexico Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 143: Mexico Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 144: Mexico Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 145: Mexico Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 146: Mexico Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 147: Rest-of-Latin America Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 148: Rest-of-Latin America Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 149: Rest-of-Latin America Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 150: Rest-of-Latin America Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 151: Rest-of-Latin America Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 152: Middle East and Africa: Market Dynamics
Figure 153: Middle East and Africa Biomanufacturing Viral Detection and Quantification Market, $Billion, 2022-2032
Figure 154: Middle East and Africa Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 155: Middle East and Africa Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 156: Middle East and Africa Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 157: Middle East and Africa Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 158: South Africa Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 159: South Africa Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 160: South Africa Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 161: South Africa Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 162: South Africa Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 163: Israel Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 164: Israel Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 165: Israel Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 166: Israel Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 167: Israel Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 168: U.A.E. Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 169: U.A.E. Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 170: U.A.E. Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 171: U.A.E. Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 172: U.A.E. Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 173: Saudi Arabia Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 174: Saudi Arabia Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 175: Saudi Arabia Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 176: Saudi Arabia Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 177: Saudi Arabia Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 178: Rest-of-Middle East and Africa Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
Figure 179: Rest-of-Middle East and Africa Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
Figure 180: Rest-of-Middle East and Africa Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
Figure 181: Rest-of-Middle East and Africa Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
Figure 182: Rest-of-Middle East and Africa Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
Figure 183: Global Biomanufacturing Viral Detection and Quantification Market, Total Number of Companies Profiled
Figure 184: Global Biomanufacturing Viral Detection and Quantification Market, Company Share Analysis, % Share, 2022
Figure 185: Danaher Corporation: Product Portfolio
Figure 186: Danaher Corporation: Overall Financials, $Million, 2020-2022
Figure 187: Danaher Corporation: Revenue (by Segment), $Million, 2020-2022
Figure 188: Danaher Corporation: Revenue (by Region), $Million, 2020-2022
Figure 189: Danaher Corporation: R&D Expenditure, $Million, 2020-2022
Figure 190: Merck KGaA: Product Portfolio
Figure 191: Merck KGaA: Overall Financials, $Million, 2020-2022
Figure 192: Merck KGaA: Revenue (by Segment), $Million, 2020-2022
Figure 193: Merck KGaA: Revenue (by Region), $Million, 2020-2022
Figure 194: Merck KGaA: R&D Expenditure, $Million, 2020-2022
Figure 195: New England Biolabs: Product Portfolio
Figure 196: TAKARA HOLDINGS INC.: Product Portfolio
Figure 197: TAKARA HOLDINGS INC.: Overall Financials, $Million, 2020-2022
Figure 198: TAKARA HOLDINGS INC.: Revenue (by Region), $Million, 2020-2022
Figure 199: TAKARA HOLDINGS INC.: R&D Expenditure, $Million, 2020-2022
Figure 200: Thermo Fisher Scientific Inc.: Product Portfolio
Figure 201: Thermo Fisher Scientific Inc.: Overall Financials, $Million, 2020-2022
Figure 202: Thermo Fisher Scientific Inc.: Revenue (by Segment), $Million, 2020-2022
Figure 203: Thermo Fisher Scientific Inc.: Revenue (by Region), $Million, 2020-2022
Figure 204: Thermo Fisher Scientific Inc.: R&D Expenditure, $Million, 2020-2022
Figure 205: Agilent Technologies, Inc.: Product Portfolio
Figure 206: Agilent Technologies, Inc.: Overall Financials, $Million, 2020-2022
Figure 207: Agilent Technologies, Inc.: Revenue (by Segment), $Million, 2020-2022
Figure 208: Agilent Technologies, Inc.: Revenue (by Region), $Million, 2020-2022
Figure 209: Agilent Technologies, Inc.: R&D Expenditure, $Million, 2020-2022
Figure 210: Sartorius AG: Product Portfolio
Figure 211: Sartorius AG: Overall Financials, $Million, 2020-2022
Figure 212: Sartorius AG: Revenue (by Segment), $Million, 2020-2022
Figure 213: Sartorius AG: Revenue (by Region), $Million, 2020-2022
Figure 214: Charles River Laboratories: Product Portfolio
Figure 215: Charles River Laboratories: Overall Financials, $Million, 2020-2022
Figure 216: Charles River Laboratories: Revenue (by Segment), $Million, 2020-2022
Figure 217: Charles River Laboratories: Revenue (by Region), $Million, 2020-2022
Figure 218: Bio-Rad Laboratories, Inc.: Product Portfolio
Figure 219: Bio-Rad Laboratories, Inc.: Overall Financials, $Million, 2020-2022
Figure 220: Bio-Rad Laboratories, Inc.: Revenue (by Segment), $Million, 2020-2022
Figure 221: Bio-Rad Laboratories, Inc.: Revenue (by Region), $Million, 2020-2022
Figure 222: Bio-Rad Laboratories, Inc.: R&D Expenditure, $Million, 2020-2022
Figure 223: PerkinElmer, Inc.: Product Portfolio
Figure 224: PerkinElmer, Inc.: Overall Financials, $Million, 2021-2023
Figure 225: PerkinElmer, Inc.: Revenue (by Segment), $Million, 2021-2023
Figure 226: PerkinElmer, Inc.: Revenue (by Region), $Million, 2021-2023
Figure 227: PerkinElmer, Inc.: R&D Expenditure, $Million, 2021-2023
Figure 228: Promega Corporation: Product Portfolio
Figure 229: QIAGEN N.V.: Product Portfolio
Figure 230: QIAGEN N.V.: Overall Financials, $Million, 2020-2022
Figure 231: QIAGEN N.V.: Revenue (by Segment), $Million, 2020-2022
Figure 232: QIAGEN N.V.: Revenue (by Region), $Million, 2020-2022
Figure 233: QIAGEN N.V.: R&D Expenditure, $Million, 2020-2022
Figure 234: Genscript Biotech Corporation: Product Portfolio
Figure 235: Genscript Biotech Corporation: Overall Financials, $Million, 2020-2022
Figure 236: Genscript Biotech Corporation: Revenue (by Segment), $Million, 2020-2022
Figure 237: Genscript Biotech Corporation: Revenue (by Region), $Million, 2020-2022
Figure 238: Genscript Biotech Corporation: R&D Expenditure, $Million, 2020-2022
Figure 239: Norgen Biotek Corp.: Product Portfolio

List of Tables

Table 1: Global Biomanufacturing Viral Detection and Quantification Market, Impact Analysis
Table 2: Key Questions Answered in the Report
Table 3: Methods of Virus Detection and Quantification
Table 4: Biomanufacturing Viral Detection and Quantification Market: Global Regulatory Scenario
Table 5: Technological Advancement in the Field of Viral Testing
Table 6: Impact Analysis: Business Drivers
Table 7: Impact Analysis: Business Restraints

02-2729-4219

+886-2-2729-4219